New Issue: NuVasive raises $129 million in follow-on of 6.7 million shares at $19.25 vs. $19.36 close

By Ronda Fears

Memphis, Feb. 2 - NuVasive, Inc. sold 6.7 million shares of common stock in a follow-on offering priced at $19.25 each versus Wednesday's close of $19.36 via joint bookrunners Banc of America Securities LLC and Lehman Brothers Inc.

The spot sale also included a secondary offering of 795,880 shares by a selling stockholder.

San Diego-based NuVasive is a medical device company focused on products for the surgical treatment of spine disorders.

Issuer:	NuVasive, Inc.
Issue:	Follow-on stock offering
Gross proceeds:	$129 million
Shares:	6,704,120 shares
Greenshoe:	1,125,000 shares
Price:	$19.25 per share
Bookrunners:	Banc of America Securities LLC and Lehman Brothers Inc.
Co-managers:	Thomas Weisel Partners LLC and William Blair & Co.
Pricing date:	Feb. 1
Settlement date:	Feb. 7
Stock symbol:	Nasdaq: NUVA
Stock price:	$19.36 at close Feb. 1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.